Cynata Therapeutics Ltd
ASX:CYP

Watchlist Manager
Cynata Therapeutics Ltd Logo
Cynata Therapeutics Ltd
ASX:CYP
Watchlist
Price: 0.355 AUD 16.39% Market Closed
Market Cap: 84.3m AUD

Wall Street
Price Targets

CYP Price Targets Summary
Cynata Therapeutics Ltd

There are no price targets for CYP.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Cynata Therapeutics Ltd Competitors:
Price Targets
REGN
Regeneron Pharmaceuticals Inc
3% Upside
MRNA
Moderna Inc
20% Upside
688177
Bio-Thera Solutions Ltd
59% Upside
300601
Shenzhen Kangtai Biological Products Co Ltd
33% Upside
APLS
Apellis Pharmaceuticals Inc
45% Upside
SLS
Sellas Life Sciences Group Inc
143% Upside
ADOC
Adocia SA
144% Upside
RCKT
Rocket Pharmaceuticals Inc
131% Upside

Revenue
Forecast

Revenue Estimate
Cynata Therapeutics Ltd

For the last 13 years the compound annual growth rate for Cynata Therapeutics Ltd's revenue is -3%. The projected CAGR for the next 3 years is 123%.

-3%
Past Growth
123%
Estimated Growth
Estimates Accuracy
-86%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cynata Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Cynata Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-60%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CYP's stock price target?
Not Available

CYP doesn't have any price targets made by Wall Street professionals.

What is Cynata Therapeutics Ltd's Revenue forecast?
Projected CAGR
123%

For the last 13 years the compound annual growth rate for Cynata Therapeutics Ltd's revenue is -3%. The projected CAGR for the next 3 years is 123%.

Back to Top